Skip to main content
profile image
Selected Works of Dave S.B. Hoon, PhD
Article
MiR-200a Regulates CDK4/6 Inhibitor Effect by Targeting CDK6 in Metastatic Melanoma
Journal of Investigative Dermatology (2017)
  • Matias A. Bustos, Department of Translational Molecular Medicine, Division of Molecular Oncology, John Wayne Cancer Institute at Providence Saint John’s Health Center, Santa Monica, California, USA
  • Shigeshi Ono, Department of Translational Molecular Medicine, Division of Molecular Oncology, John Wayne Cancer Institute at Providence Saint John’s Health Center, Santa Monica, California, USA
  • Diego M. Marzese, Department of Translational Molecular Medicine, Division of Molecular Oncology, John Wayne Cancer Institute at Providence Saint John’s Health Center, Santa Monica, California, USA
  • Takashi Oyama, Department of Translational Molecular Medicine, Division of Molecular Oncology, John Wayne Cancer Institute at Providence Saint John’s Health Center, Santa Monica, California, USA
  • Yuuki Iida, Department of Translational Molecular Medicine, Division of Molecular Oncology, John Wayne Cancer Institute at Providence Saint John’s Health Center, Santa Monica, California, USA
  • Garrett Cheung, Department of Translational Molecular Medicine, Division of Molecular Oncology, John Wayne Cancer Institute at Providence Saint John’s Health Center, Santa Monica, California, USA
  • Nellie Nelson, Sequencing Center, John Wayne Cancer Institute at Providence Saint John’s Health Center, Santa Monica, California, USA
  • Sandy C. Hsu, Department of Translational Molecular Medicine, Division of Molecular Oncology, John Wayne Cancer Institute at Providence Saint John’s Health Center, Santa Monica, California, USA
  • Qiang Yu, Agency for Science, Technology and Research
  • Dave S.B. Hoon
Link
Disciplines
Publication Date
September 1, 2017
DOI
10.1016/j.jid.2017.03.039
Citation Information
Matias A. Bustos, Shigeshi Ono, Diego M. Marzese, Takashi Oyama, et al.. "MiR-200a Regulates CDK4/6 Inhibitor Effect by Targeting CDK6 in Metastatic Melanoma" Journal of Investigative Dermatology Vol. 137 Iss. 9 (2017) p. 1955 - 1964
Available at: http://works.bepress.com/dave-hoon/45/